{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:27:18Z","timestamp":1779114438696,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2024-NHLHCRF-YS-01"],"award-info":[{"award-number":["2024-NHLHCRF-YS-01"]}]},{"name":"Capital\u2019s Founds for Health Improvement and Research","award":["No. 2022-1-4062"],"award-info":[{"award-number":["No. 2022-1-4062"]}]},{"name":"Beijing Research Ward Construction Clinical Research Project","award":["2022-YJXBF-04-03"],"award-info":[{"award-number":["2022-YJXBF-04-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10557-025-07720-2","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:48:53Z","timestamp":1749527333000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Angiotensin-Converting Enzyme Inhibitors\/Angiotensin II Receptor Blockers on Prognosis in Acute Coronary Syndrome Patients with Preserved Ejection Fraction Undergoing Regular Dialysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Yike","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enmin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaliu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxue","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyue","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-6166","authenticated-orcid":false,"given":"Jingang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"7720_CR1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA. Global burden of cardiovascular diseases and risks, 1990\u20132022. J Am Coll Cardiol. 2023;82:2350\u2013473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007","journal-title":"J Am Coll Cardiol"},{"key":"7720_CR2","doi-asserted-by":"publisher","unstructured":"Timmis A, Aboyans V, Vardas P, et al. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics. Eur Heart J. 2024;ehae466. https:\/\/doi.org\/10.1093\/eurheartj\/ehae466","DOI":"10.1093\/eurheartj\/ehae466"},{"key":"7720_CR3","doi-asserted-by":"publisher","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"7720_CR4","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation. 2014;130:2354\u201394. https:\/\/doi.org\/10.1161\/CIR.0000000000000133","journal-title":"Circulation"},{"key":"7720_CR5","doi-asserted-by":"publisher","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 1995;333:1670\u20131676. https:\/\/doi.org\/10.1056\/NEJM199512213332503","DOI":"10.1056\/NEJM199512213332503"},{"key":"7720_CR6","doi-asserted-by":"publisher","unstructured":"Pfeffer MA, Braunwald E, Moy\u00e9 LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669\u2013677. https:\/\/doi.org\/10.1056\/NEJM199209033271001","DOI":"10.1056\/NEJM199209033271001"},{"key":"7720_CR7","doi-asserted-by":"publisher","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821\u2013828. https:\/\/doi.org\/10.1016\/0140-6736(93)92693-N","DOI":"10.1016\/0140-6736(93)92693-N"},{"key":"7720_CR8","doi-asserted-by":"publisher","unstructured":"Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782\u2013788. https:\/\/doi.org\/10.1016\/s0140-6736(03)14286-9","DOI":"10.1016\/s0140-6736(03)14286-9"},{"key":"7720_CR9","doi-asserted-by":"publisher","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145\u2013153. https:\/\/doi.org\/10.1056\/NEJM200001203420301","DOI":"10.1056\/NEJM200001203420301"},{"key":"7720_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00392-021-01985-x","volume":"111","author":"HC Prosser","year":"2022","unstructured":"Prosser HC, Peck KY, Dinh D, et al. Role of renin-angiotensin system antagonists on long-term mortality post-percutaneous coronary intervention in reduced and preserved ejection fraction. Clin Res Cardiol. 2022;111:776\u201386. https:\/\/doi.org\/10.1007\/s00392-021-01985-x","journal-title":"Clin Res Cardiol"},{"key":"7720_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.rec.2019.02.012","volume":"73","author":"S Raposeiras-Roub\u00edn","year":"2020","unstructured":"Raposeiras-Roub\u00edn S, Abu-Assi E, Cesp\u00f3n-Fern\u00e1ndez M, et al. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. Rev Esp Cardiol (Engl Ed). 2020;73:114\u201322. https:\/\/doi.org\/10.1016\/j.rec.2019.02.012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"7720_CR12","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2017.4046","volume":"317","author":"AK Bello","year":"2017","unstructured":"Bello AK, Levin A, Tonelli M, et al. Assessment of global kidney health care status. JAMA. 2017;317:1864\u201381. https:\/\/doi.org\/10.1001\/jama.2017.4046","journal-title":"JAMA"},{"issue":"9","key":"7720_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.kisu.2018.11.001","volume":"2019","author":"L Zhang","year":"2011","unstructured":"Zhang L, Zhao M-H, Zuo L, et al. China Kidney Disease Network (CK-NET) 2015 annual data report. Kidney Int Suppl. 2011;2019(9):e1\u201381. https:\/\/doi.org\/10.1016\/j.kisu.2018.11.001","journal-title":"Kidney Int Suppl"},{"key":"7720_CR14","doi-asserted-by":"publisher","first-page":"e005879","DOI":"10.1161\/CIRCOUTCOMES.119.005879","volume":"12","author":"K Szummer","year":"2019","unstructured":"Szummer K, Lindhagen L, Evans M, et al. Treatments and mortality trends in cases with and without dialysis Who have an acute myocardial infarction: an 18-year nationwide experience. Circ Cardiovasc Qual Outcomes. 2019;12:e005879. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005879","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"7720_CR15","doi-asserted-by":"publisher","first-page":"663811","DOI":"10.3389\/fphar.2022.663811","volume":"13","author":"R Chen","year":"2022","unstructured":"Chen R, Liu C, Zhou P, et al. Prognostic impacts of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute coronary syndrome patients without heart failure. Front Pharmacol. 2022;13:663811. https:\/\/doi.org\/10.3389\/fphar.2022.663811","journal-title":"Front Pharmacol"},{"key":"7720_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/eurheartj\/ehu078","volume":"35","author":"E Sorbets","year":"2014","unstructured":"Sorbets E, Labreuche J, Simon T, et al. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure. Eur Heart J. 2014;35:1760\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehu078","journal-title":"Eur Heart J"},{"key":"7720_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40256-019-00343-7","volume":"19","author":"M Cesp\u00f3n-Fern\u00e1ndez","year":"2019","unstructured":"Cesp\u00f3n-Fern\u00e1ndez M, Raposeiras-Roub\u00edn S, Abu-Assi E, et al. Renin-angiotensin system blockade and risk of heart failure after myocardial infarction based on left ventricular ejection fraction: a retrospective cohort study. Am J Cardiovasc Drugs. 2019;19:487\u201395. https:\/\/doi.org\/10.1007\/s40256-019-00343-7","journal-title":"Am J Cardiovasc Drugs"},{"key":"7720_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","volume":"67","author":"M Evans","year":"2016","unstructured":"Evans M, Carrero J-J, Szummer K, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction. J Am Coll Cardiol. 2016;67:1687\u201397. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.050","journal-title":"J Am Coll Cardiol"},{"key":"7720_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/ehjqcco\/qcad006","volume":"9","author":"Z Li","year":"2023","unstructured":"Li Z, Sun H, Hao Y, et al. Renin-angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health record-based cohort in China. Eur Heart J Qual Care Clin Outcomes. 2023;9:785\u201395. https:\/\/doi.org\/10.1093\/ehjqcco\/qcad006","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"7720_CR20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ndt\/gfw053","volume":"32","author":"JI Shen","year":"2017","unstructured":"Shen JI, Saxena AB, Montez-Rath ME, et al. Angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplan. 2017;32:862\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfw053","journal-title":"Nephrol Dial Transplan"},{"key":"7720_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/imj.13971","volume":"48","author":"H-F Lee","year":"2018","unstructured":"Lee H-F, See L-C, Chan Y-H, et al. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study. Intern Med J. 2018;48:1123\u201332. https:\/\/doi.org\/10.1111\/imj.13971","journal-title":"Intern Med J"},{"key":"7720_CR22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.amjmed.2020.03.037","volume":"133","author":"EO Gosmanova","year":"2020","unstructured":"Gosmanova EO, Molnar MZ, Naseer A, et al. Longer predialysis ACEi\/ARB utilization is associated with reduced postdialysis mortality. Am J Med. 2020;133:1065-1073.e3. https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.037","journal-title":"Am J Med"},{"key":"7720_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jemermed.2020.05.001","volume":"59","author":"JD Farkas","year":"2020","unstructured":"Farkas JD, Long B, Koyfman A, Menson K. BRASH syndrome: bradycardia, renal failure, AV blockade, shock, and hyperkalemia. J Emerg Med. 2020;59:216\u201323. https:\/\/doi.org\/10.1016\/j.jemermed.2020.05.001","journal-title":"J Emerg Med"},{"key":"7720_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000491552","volume":"48","author":"E Movilli","year":"2018","unstructured":"Movilli E, Camerini C, Gaggia P, et al. Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. Am J Nephrol. 2018;48:79\u201386. https:\/\/doi.org\/10.1159\/000491552","journal-title":"Am J Nephrol"},{"key":"7720_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000482013","volume":"46","author":"R Kido","year":"2017","unstructured":"Kido R, Akizawa T, Fukagawa M, et al. Interactive effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers or their combination on survival of hemodialysis patients. Am J Nephrol. 2017;46:439\u201347. https:\/\/doi.org\/10.1159\/000482013","journal-title":"Am J Nephrol"},{"key":"7720_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ki.2011.228","volume":"80","author":"KE Chan","year":"2011","unstructured":"Chan KE, Ikizler TA, Gamboa JL, et al. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int. 2011;80:978\u201385. https:\/\/doi.org\/10.1038\/ki.2011.228","journal-title":"Kidney Int"},{"key":"7720_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","volume":"114","author":"MH Strauss","year":"2006","unstructured":"Strauss MH, Hall AS. Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation. 2006;114:838\u201354. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.594986","journal-title":"Circulation"},{"key":"7720_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/1470320314535276","volume":"16","author":"Z Kiss","year":"2015","unstructured":"Kiss Z, Ambrus C, Kulcs\u00e1r I, et al. Effect of angiotensin-converting enzyme gene insertion\/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis. J Renin Angiotensin Aldosterone Syst. 2015;16:1021\u20137. https:\/\/doi.org\/10.1177\/1470320314535276","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07720-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:05:35Z","timestamp":1773698735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07720-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7720"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07720-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"15 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"China-Japan Friendship Hospital Ethics Committee (2020\u2013112-K71) approved this study without informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent for participation in the study was obtained from all the individual participants involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}